JP2007514763A5 - - Google Patents

Download PDF

Info

Publication number
JP2007514763A5
JP2007514763A5 JP2006545542A JP2006545542A JP2007514763A5 JP 2007514763 A5 JP2007514763 A5 JP 2007514763A5 JP 2006545542 A JP2006545542 A JP 2006545542A JP 2006545542 A JP2006545542 A JP 2006545542A JP 2007514763 A5 JP2007514763 A5 JP 2007514763A5
Authority
JP
Japan
Prior art keywords
carboxylesterase
composition
combination
compound
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006545542A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007514763A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/042717 external-priority patent/WO2005063225A1/en
Publication of JP2007514763A publication Critical patent/JP2007514763A/ja
Publication of JP2007514763A5 publication Critical patent/JP2007514763A5/ja
Pending legal-status Critical Current

Links

JP2006545542A 2003-12-19 2004-12-18 C型肝炎ウイルス(hcv)の感染を処置するための組成物および方法 Pending JP2007514763A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53154303P 2003-12-19 2003-12-19
PCT/US2004/042717 WO2005063225A1 (en) 2003-12-19 2004-12-18 Compositions and methods for treating hepatitis c virus (hcv) infection

Publications (2)

Publication Number Publication Date
JP2007514763A JP2007514763A (ja) 2007-06-07
JP2007514763A5 true JP2007514763A5 (enExample) 2008-02-14

Family

ID=34738664

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006545542A Pending JP2007514763A (ja) 2003-12-19 2004-12-18 C型肝炎ウイルス(hcv)の感染を処置するための組成物および方法

Country Status (7)

Country Link
US (1) US20050249805A1 (enExample)
EP (1) EP1699446B1 (enExample)
JP (1) JP2007514763A (enExample)
AT (1) ATE396718T1 (enExample)
DE (1) DE602004014189D1 (enExample)
ES (1) ES2308302T3 (enExample)
WO (1) WO2005063225A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7971730B2 (en) 2005-08-10 2011-07-05 The Regents Of The University Of California Collection tubes apparatus, systems and methods
JP2010528666A (ja) * 2007-06-08 2010-08-26 エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント カルボキシエステラーゼ−1多型およびその使用方法
US20090017108A1 (en) * 2007-07-11 2009-01-15 Alexander Yuzhakov Liposome compositions for treatment of hepatitis C
US8182826B2 (en) * 2007-09-11 2012-05-22 Whitmire A Jeffrey Refreshment towel and applied solution
US10966431B2 (en) * 2007-09-11 2021-04-06 Freedom Towel Holdings, LLC. Refreshment towel and applied solution
US9669405B2 (en) 2012-10-22 2017-06-06 The Regents Of The University Of California Sterilizable photopolymer serum separator
US10154947B2 (en) 2016-01-06 2018-12-18 The Procter & Gamble Company Antiperspirant composition
US9730867B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Methods of forming a slurry with microcapsules formed from phosphate esters
US9732303B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Microcapsules formed from phosphate esters and compositions containing same
CN110220757B (zh) * 2019-06-05 2021-08-24 浙江龙传生物医药科技有限公司 用于药物代谢检测的血液保存剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971618A (en) * 1971-04-16 1990-11-20 Ici Americas Inc. Herbicide compositions
EP1348706B1 (en) * 2000-12-08 2009-08-19 Takeda Pharmaceutical Company Limited Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
PL374536A1 (en) * 2002-08-23 2005-10-31 Rigel Pharmaceuticals, Inc. Pyridyl substituted heterocycles useful for treating or preventing hcv infection

Similar Documents

Publication Publication Date Title
RU2436780C2 (ru) Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы
JP2009530398A5 (enExample)
JP2010502730A5 (enExample)
JP2018515555A5 (enExample)
JP2006505543A5 (enExample)
AR083542A1 (es) Piperidin-4-il-azetidin diamidas como inhibidores de monoacilglicerol lipasa
JPWO2020085493A5 (enExample)
JP2007514763A5 (enExample)
RU2009131454A (ru) Способы предупреждения или уменьшения числа обострений подагры с применением ингибиторов ксантиноксидоредуктазы и противовоспалительных средств
JP2017515844A5 (enExample)
JP2011502958A5 (enExample)
RU2013119129A (ru) Органические соединения
JP2011505347A5 (enExample)
JP2015536997A5 (enExample)
JP2013533253A5 (enExample)
CN114728910A (zh) 用于fgfr抑制剂的吡唑类衍生物及其制备方法
JP2017502092A5 (enExample)
JP2019520344A5 (enExample)
JP2019065009A5 (enExample)
JP2009184932A5 (enExample)
JP2007522159A5 (enExample)
JP2005502636A5 (enExample)
JP2019182865A5 (enExample)
JPWO2023095860A5 (enExample)
JP2009501745A5 (enExample)